If the protein TDP-43 is defective inside a nerve cell it can form neurotoxic aggregates, which are the cause of the ...

A new screening instrument can identify cognitive impairment in patients with ALS both within and beyond the established FTD ...

RNS60 was well tolerated when inhaled twice daily at home as part of an expanded access program (EAP) for people with ...

A Series in The Lancet Neurology provides state-of-the-art reviews covering clinical and scientific evidence on the four most common genetic subtypes of amyotrophic lateral sclerosis (ALS), caused by ...

Actor Eric Dane recently announced that he has been diagnosed with amyotrophic lateral sclerosis (ALS), a degenerative and ...

The 52-year-old actor says he will return to the set of "Euphoria" next week and feels "fortunate" to be able to continue ...

In a phase 3, open-label safety extension study, researchers evaluated the safety of oral edaravone in patients with amyotrophic lateral sclerosis over 96 weeks.

The first ALS patient has been enrolled in an NIH-funded expanded access program trial evaluating MN-166 (ibudilast).

Actor Eric Dane, known for Grey's Anatomy and Euphoria, has revealed his diagnosis with Amyotrophic Lateral Sclerosis (ALS), ...

The "Grey's Anatomy" alum shared that he has been diagnosed with amyotrophic lateral sclerosis (ALS), which ... paralysis of the muscles, causing patients to slowly lose the ability to speak ...

"Grey's Anatomy" and "Euphoria" star Eric Dane said he is still able to work and will return to the HBO drama.

today announces the enrollment of the first patient in its phase I/II clinical trial for treating Amyotrophic Lateral Sclerosis (ALS), a fatal disease. Enrollment in phase I commenced in Australia at ...